| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.46B | +3.2% |
| Cost of Revenue | $1.27B | +12.4% |
| Gross Profit | $1.19B | -5.2% |
| R&D Expense | $67.8M | +4.6% |
| SG&A Expense | $801.6M | -9.7% |
| Operating Income | $304.3M | +6.6% |
| Pre-tax Income | $249.7M | +3.3% |
| Income Tax | $47.8M | +11.2% |
| Net Income | $214.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $218.4M | +8.5% |
| Inventory | $576.0M | -6.4% |
| Current Assets | $973.9M | -2.3% |
| Total Assets | $2.18B | -0.7% |
| Current Liabilities | $472.7M | +4.8% |
| Long-term Debt | $757.5M | +11.9% |
| Total Liabilities | $1.38B | +7.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $245.1M | -34.1% |
| Capital Expenditures | $74.6M | -1.0% |
| Investing Cash Flow | -$74.6M | +26.5% |
| Financing Cash Flow | -$179.7M | +32.1% |
| Free Cash Flow | $170.5M | -42.5% |
| +8.0% |
| EPS (Basic) | $3.38 | +14.2% |
| EPS (Diluted) | $3.37 | +14.6% |
| Stockholders' Equity |
| $765.2M |
| -11.5% |